Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise?
Sarcopenia, a loss of muscle mass, is being increasingly recognized to have a deleterious effect on outcomes in patients with chronic liver disease. Factors related to diet and the inflammatory nature of chronic liver disease contribute to the occurrence of sarcopenia in these patients. Sarcopenia adversely influences quality of life, performance, morbidity, success of transplantation, and even mortality. Specific deficiencies in macronutrients (protein, polyunsaturated fatty acids) and micronutrients (vitamins C, D, and E, carotenoids, and selenium) have been linked to sarcopenia. Lessons learned from nutritional therapy in geriatric patient populations may provide strategies to manage sarcopenia in patients with liver disease. Combining diet modification and nutrient supplementation with an organized program of exercise may help ameliorate or even reverse the effects of sarcopenia on an already complex disease process.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Vitamin D
- Sarcopenia
- Liver Diseases
- Humans
- Gastroenterology & Hepatology
- Fatty Acids, Unsaturated
- Exercise
- Dietary Supplements
- Combined Modality Therapy
- Chronic Disease
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Vitamin D
- Sarcopenia
- Liver Diseases
- Humans
- Gastroenterology & Hepatology
- Fatty Acids, Unsaturated
- Exercise
- Dietary Supplements
- Combined Modality Therapy
- Chronic Disease